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_____________________________________________________________________________  
 Palladium-catalyzed borylation and Suzuki coupling (BSC) in a one pot procedure was 
successfully applied to the synthesis of several β-substituted dehydrophenylalanines in the 
benzo[b]thiophene series maintaining the stereochemistry of the starting materials.  
Bromobenzo[b]thiophenes bearing an ortho EDG (OMe or Me) were  used as the components to 
be borylated with pinacolborane. Pure stereoisomers of β-bromodehydrophenylalanines were 
used as the other Suzuki coupling component. Treatment of the methyl ester of N-(tert-
butoxycarbonyl)-(Z)-β-(2,3,5-trimethylbenzo[b]thien-6-yl)dehydrophenylalanine thus obtained, 
with Pd(OAc)2 and Cu(OAc)2  in DMF at 160 oC gave two indole derivatives (1:3). The major 
product  resulting from isomerization and cyclization and the minor product resulting from direct 
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cyclization (thienoindole). Reaction at 100 oC gave the same products in similar amounts. Using 
as starting material the methyl ester of N-(tert-butoxycarbonyl)-(Z)-β-(2,3,7-
trimethylbenzo[b]thien-6-yl)dehydrophenylalanine gave only one product, resulting from 
isomerization and cyclization at 100 oC. Two of the cyclized compounds were submitted to 
fluorescence studies; the thienoindole could be used as a fluorescent probe. Preliminary studies 
of antimicrobial activity were performed on the precursors and on the cyclized products. 
_____________________________________________________________________________ 
 
Introduction 
 
In recent years we have been interested in the linkage of dehydroamino acid derivatives to 
benzo[b]thiophenes and in the study of the fluorescence and antimicrobial activity of the 
resulting products. Using Suzuki coupling we were able to synthesize either β-benzo[b]thienyl or 
β, β-bis(benzo[b]thienyl)dehydroamino acid derivatives.[1,2]  The latter were cyclized to the 
corresponding dehydroprolines using a metal-assisted intramolecular cyclization and the 
fluorescence properties of one of them were studied.[2b]  
Here we describe the application of the one pot borylation Suzuki coupling (BSC) to the 
synthesis of new benzo[b]thienyldehydrophenylalanine derivatives from methylated or 
methoxylated benzo[b]thiophenes and brominated dehydrophenylalanines. This method was first 
applied by Baudoin et al. [3] to the synthesis of  2,2’-disubstituted biaryl compounds. Substituted 
halobenzenes were submitted to borylation using pinacolborane, followed by in situ Suzuki 
cross-coupling with a second 2-substituted halobenzene. The authors postulated that the 
borylation should be performed on the component bearing an ortho-EDG and the other coupling 
component having an ortho-EWG. The method is also based on the use of the electron-rich 
sterically hindered 2-(dicyclohexylphosphino)biphenyl as ligand.[4]  Recently we applied this 
reaction to the synthesis of  2-methyl-2’-nitrobiaryl compounds in the benzo[b]thiophene series 
to obtain thienocarbazoles.[5] More recently another application of the BSC to the synthesis of 
substituted biaryl compounds appeared, using DPEphos as ligand and CsF as base in the Suzuki 
coupling.[6]   
In this work  the brominated Suzuki coupling component is not aromatic and this constitutes a 
novel application of the BSC reaction as reported by us previously.[7] The C-N metal-assisted 
cyclization[2] of  differently ortho-methylated Z-β-benzo[b]thienyldehydrophenylalanine 
derivatives was studied. A thienoindole thus obtained showed to be fluorescent. Preliminary 
antimicrobial studies were performed either on the precursors or on the cyclized products. 
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Results and Discussion 
Synthesis 
 
Several benzo[b]thienyldehydrophenylalanines were prepared by palladium-catalyzed BSC 
reaction of bromobenzo[b]thiophenes ortho-substituted with an EDG group (OMe or Me) and 
pure stereoisomers of the methyl ester of N-(tert-butoxycarbonyl)-β-
bromodehydrophenylalanine,  Boc-(Z)-∆Phe-(β-Br)-OMe) (Z)-1 and Boc-(E)-∆Phe-(β-Br)-OMe 
(E)-1 already prepared by us.[1]  The bromobenzo[b]thiophenes were borylated with 
pinacolborane  followed by Suzuki coupling with (Z)-1 or (E)-1 in a one pot procedure (Scheme 
1, Table 1).   
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Table 1: Starting materials and product yields of BSC reaction.   
Benzo[b]thiophene dehydrophenylalanine Products Yield (%) 
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In all cases debrominated benzo[b]thiophenes were isolated as by-products (25-50%). When 
the two components were aromatic the component to be borylated needs an EDG and the other 
Suzuki coupling component requires an EWG.[3, 5]  In our case however the carbamate group of 
the dehydroamino acid derivative has a slight electron donating effect and this can affect the 
product yields which were moderate to good (Table 1). The products maintained the 
stereochemistry of the starting materials as observed by NOE difference experiments. 
Enhancements on the phenyl protons for the E isomers and on the ortho-methyl or methoxy and 
on the benzo[b]thienyl protons  for the Z isomers were observed irradiating the αNH as shown as 
examples in Fig. 1 and 2 for compounds (Z)-3 and (E)-3. In Fig.1 we observe an enhancement of 
the 7-Me (δ 2.39 ppm) and of the doublet of  5-H (δ 7.06 ppm). In Fig 2 the NOE enhancement 
is only observed for the phenyl protons. 
 
 
  6
 
 
Fig. 1- 1H-NMR (CDCl3) spetrum and NOE difference experiment irradiating the αNH of 
compound (Z)-3. 
N CO2MeBoc
H
S
(Z)-3
7-Me 
5-H 
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Fig. 2- 1H-NMR (CDCl3) spetrum and NOE difference experiment irradiating the αNH of 
compound (E)-3. 
 
In order to obtain cyclic amino acids, compound (Z)-2 and (Z)-3 were submitted to our 
cyclization conditions[2] (Scheme 2 and 3). Compound (Z)-2 gave two cyclized products 
resulting either from isomerization followed by cyclization giving indole 5 (major product), or  
from direct cyclization giving thienoindole 6. The reaction was also performed at 100 oC for 6h 
but the same compounds were obtained in similar amounts. 
 
 
N CO2MeBoc
H
S(E)-3
  8
Scheme 2
i) Pd(OAc)2 (50 mol%), Cu(OAc)2.H2O (3 equiv.), DMF, 160 oC, 2h 30min.
i
(Z)-2
N
H
CO2Me
S
5, 60%
+
N
H
CO2Me
S
6, 20%
 
 
 
Compound (Z)-3 was also submitted to the same conditions heating at 100 oC for 2h but a 
cyclized intermediate 7, resulting from isomerization and cyclization without N-deprotection was 
formed (this compound was isolated from an independent experiment stopping the reaction at 
that time). Heating at 130 oC for an additional hour gave the corresponding N-deprotected 
dehydroproline derivative in high yield. In this case no product resulting from direct cyclization 
of the starting material was isolated. This could be due to the much more favorable cyclization  
on the phenyl ring than on position 5 of the benzo[b]thiophene moiety.  
We believe that the mechanism of cyclization involves an electrophylic attack of Pd(II) on the 
aromatic ring and a nucleophylic attack of nitrogen forming a palladacycle. The indole being 
formed after Pd(0) extrusion. The role of the Cu(OAc)2 can be the reoxidation of Pd(0) avoiding 
the use of stoichiometric amounts of Pd(OAc)2 (Scheme 4). In our case N-deprotection also 
occurs depending on the reaction conditions (temperature and/or time). 
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Scheme 3
i) Pd(OAc)2 (50 mol%), Cu(OAc)2.H2O (3 equiv.), DMF.
i
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Scheme 4
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In vitro antimicrobial activity 
 
A screening of antibacterial activities using two Gram negative (Escherichia coli and 
Pseudomonas aeruginosa) and two Gram positive bacteria (Bacillus subtilis and Bacillus cereus) 
and antifungal using Candida albicans  as a representative of fungi was assessed for compounds 
(Z)-2, (Z)-3, 5, 6, 7 and  8. The minimal inhibitory concentration  (MIC in µg/mL) was 
determined (Table 2) using an adaptation of agar streak dilution method based on radial 
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diffusion.[8] In the same conditions different concentrated solutions of Ampicillin (antibacterial) 
and Cyclohexamide (antifungal) were used as standards. The MIC was considered to be the 
lowest concentration of the tested compound which inhibits growth of bacteria or fungi on the 
plate. The diameters of the inhibition zones corresponding to the MICs are presented in Table 2. 
The compounds tested are not active against Pseudomonas aeruginosa starting from DMSO 
solutions of  6000 µg/mL of each compound. Compounds (Z)-2, (Z)-3 are also not active against 
Escherichia coli but are the only ones active against Candida albicans, being (Z)-2 (MIC 6 
µg/mL) more active than (Z)-3 (MIC 600 µg/mL) and than Cyclohexamide (MIC 12.5 µg/mL). 
Against Gram positive bacteria (Z)-2 is more active against B. cereus but (Z)-3 shows a lower 
MIC against B. subtilis, even lower than Ampicillin. 
Against Escherichia coli indole 7 and 8 are more active (MIC 0.06 µg/mL) than thienoindole 6 
(MIC 0.6 µg/mL). All the cyclized products are active against Gram positive bacteria, presenting 
lower MICs than their precursors (Z)-2, (Z)-3 and Ampicillin, indole 7 being the most active 
(MIC 0.006 µg/mL). 
 
Table 2. Antimicrobial activity of compounds (Z)-2, (Z)-3, 5, 6, 7 and  8 
 
Compounds 
 
MIC in µg/mL    (Zone of inhibition in mm ) 
 E. coli 
CECT 101 
B. cereus 
CECT148 
B.  subtilis 
CECT498 
C.  albicans 
CECT 1394 
(Z)-2  not activea 6 (10) 60 (11) 6 (8) 
(Z)-3  not activea 60 (12) 6 (8) 600 (9) 
Indole 5 600 (11) 0.6 (13) 0.6 (9) not activea 
Thienoindole 6 0.6 (7) 0.06 (10) 0.06 (9) not activea 
Indole 7 0.06 (8) 0.006 (10) 0.006 (13) not activea 
Indole 8 0.06 (11) 0.06 (9) 0.06 (8) not activea 
Ampicillin 6.25 (15) 3.13 (13) 12.5 (10) ______ 
Cyclohexamide ______ ______ ______ 12.5 (5) 
CECT-Spanish type culture collection of Valencia University 
a Not active starting from 6000 µg/mL 
 
Fluorescence studies  
 
The fluorescence of compounds 5 and 6 was studied (Fig 3).  Thienoindole  6  showed a λem= 
393 nm and a relative quantum yield of fluorescence in dichloromethane Φdcm = 0.33, using the 
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standard method[9]  with  9,10-diphenylanthracene in EtOH (2x10-5 M) as reference (ΦEtOH = 
0.95)[10]  using λexc = 333 nm. Indole 5 showed a λem = 408 nm and a relative quantum yield of 
fluorescence in dichloromethane Φdcm = 0.0067  using the same method and λexc = 296 nm. The 
excitation wavelengths (λexc) were chosen from the UV spectra of the compounds (see 
experimental). From the results obtained it can be concluded that thienoindole 6 can be used as a 
fluorescent probe. 
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Fig. 3. Fluorescence spectra of compounds 5 and 6 in dichloromethane (1.6x10-6 M). 
 
Conclusions 
Several new β-benzo[b]thienyldehydrophenylalanines were synthesized in moderate to good 
yields from ortho-substituted bromobenzo[b]thiophenes and pure stereoisomers of β-brominated 
dehydrophenylalanines by one pot borylation and Suzuki coupling (BSC), maintaining the 
stereochemistry of the starting materials. Two of the Z isomers obtained, (Z)-2 and (Z)-3, were 
submitted to C-N metal-assisted cyclization giving dehydroprolines (indoles and a thienoindole). 
From preliminary antimicrobial studies on the precursors and on the cyclized products it is 
possible to conclude that all the compounds were active against the Gram positive bacteria (B. 
cereus and B. subtilis), the cyclized products being more active (lower MICs). The latter were 
also active against E. coli despite presenting very different MICs and in turn the precursors were 
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the only compounds active against Candida albicans. Fluorescence studies on compounds 5 and 
6 show that the thienoindole 6 can be used as a fluorescent probe. 
 
Experimental Section 
 
General Remarks: Melting points were determined on a Gallenkamp apparatus and are uncorrected. The 1H 
NMR spectra were measured on a Varian Unity Plus at 300 MHz. Spin-spin decoupling techniques were used to 
assign the signals. NOE difference experiments were performed to determine the stereochemistry of the products. 
The 13C NMR spectra were measured in the same instrument at 75.4 MHz (using DEPT θ 45º). The UV spectra 
were recorded  on a Schimadzu UV-250 1PC, UV-vis recording spectrophotometer.               
 Elemental analyses were determined on a LECO CHNS 932 elemental analyser. Mass spectra (EI) and HRMS 
were made by the mass spectrometry service of University of Vigo-Spain. 
Column chromatography was performed on Macherey-Nagel silica gel 230-400 mesh. Petroleum ether refers to the 
boiling range 40-60 oC. Ether refers to diethyl ether. When solvent gradient was used the increase of polarity was 
done gradually from neat petroleum ether to mixtures of ether/petroleum ether increasing 10% of ether until the 
isolation of the product.  
For the  in vitro antimicrobial activity, suspensions  of the microorganism were prepared to contain approximately 
108 cfu/mL and the plates were inoculated. A stock solution of the synthesized compound (6000 µg/mL) in DMSO 
was prepared and graded dilutions (10x) of the tested compounds were incorporated in a cavity (depth 3mm, 
diameter 4mm) made in the center of the petridish (nutrient agar for antibacterial activity and sabouraud dextrose 
agar medium for antifungal activity). The plates were incubated at 37 oC (for bacteria) and at 30 oC (for fungi) for 
24h in duplicate. Positive control using only inoculation and negative control using only DMSO in the cavity were 
carried out.  
The fluorescence studies were performed  on a spectrofluorimeter Spex Fluorolog 1680 Double Spectrometer.  
Samples quantum yields are given by rrnrFsAsnsFrAs Φ⎥⎦
⎤⎟⎠
⎞⎜⎝
⎛⎢⎣
⎡ ⎟⎠
⎞⎜⎝
⎛=Φ 2/2  where A is the absorbance at the excitation 
wavelength, F the integrated emission area and n the refraction index of the solvents used. Subscripts refer to the 
reference (r) or sample (s) compound.  
Compounds (Z)-1 and  (E)-1 were already described by us.[1] The 6-bromotrimethylbenzo[b]thiophenes were 
prepared according to a procedure described by others[11a]  and previously used by us.[11b]  
 
7-Bromo-2,3-dimethyl-6-methoxybenzo[b]thiophene and 5-bromo-2,3-dimethyl-6-methoxy-
benzo[b]thiophene: To a cooled solution 0 ºC of  6-methoxy-2,3-dimethylbenzo[b]thiophene[12] (3.00 mmol, 0.500 
g)  in dry ether (30 mL) protected against light it was added 1 equiv. of Br2 (3.00 mmol, 0.154 mL) and a small 
amount of  Fe. The reaction was followed by 1H-NMR and it was left stirring for 1h. Iced water (10mL) was added 
and the mixture was stirring for 10 min. The phases were separated and the aqueous phase was extracted with more 
ether (2x30 mL). The organic phases were collected, washed with a 5% solution of sodium sulfite and a 10% 
solution of sodium carbonate and dried (MgSO4). Removal of the solvent gave a solid that was submitted to column 
chromatography using a petroleum ether. 5-Bromo-2,3-dimethyl-6-methoxybenzo[b]thiophene (62.0 mg, 8 %) 
was isolated as the less polar product as a white solid, m.p. 119 – 120 ºC. 1H NMR (CDCl3): δ 2.24 (s, 3 H, ArCH3), 
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2.45 (s, 3 H, ArCH3), 3.95 (s, 3 H, OCH3), 7.25 (s, 1 H, 7-H), 7.74 (s, 1 H, 4-H) ppm. 13C NMR (CDCl3): δ11.29 
(CH3), 13.65 (CH3), 56.44 (OCH3), 104.53 (CH), 109.34 (C), 125.27 (CH), 125.94 (C), 132.40 (C), 136.01 (C), 
138.08 (C), 152.54 (C) ppm. C11H11BrOS (271.17): calc. C 48.72, H 4.09, S 11.82; found C 48.87, H 4.23, S 11.60; 
followed by  7-bromo-2,3-dimethyl-6-methoxybenzo[b]thiophene (484 mg, 60%) isolated as a white solid, m.p. 
120–122 ºC. 1H NMR (CDCl3): δ 2.26 (s, 3 H, ArCH3), 2.46 (s, 3 H, ArCH3), 3.97 (s, 3 H, OCH3), 7.00 (d, J = 8.4 
Hz, 1 H, 5-H), 7.48 (d, J = 8.4 Hz, 1 H, 4-H) ppm. 13C NMR (CDCl3): δ11.60 (CH3), 13.67 (CH3), 57.05 (OCH3), 
103.97 (C), 109.73 (CH), 120.39 (CH), 127.39 (C), 132.55 (C), 135.85 (C), 141.55 (C), 152.74 (C) ppm. 
C11H11BrOS (271.17): calc. C 48.72, H 4.09, S 11.82; found C 49.00, H 4.27, S 11.74. 
 
 
General procedure for one-pot BSC Reaction: A dried Schlenk tube was charged under Ar with dry dioxane (2 
mL), the ortho-methylated or methoxylated bromobenzo[b]thiophene (0.5 mmol) was added and the mixture heated 
for 5 min. at 80 ºC. Triethylamine (4 equiv.), Pd(OAc)2 (5 mol%), 2-(dicyclohexylphosphino)biphenyl (20 mol%) 
and pinacolborane (3 equiv.) were added, and the mixture was left with rapid stirring at 80 ºC for 1h. After cooling, 
a pure stereoisomer of β-bromodehydrophenylalanine derivative (1 equiv.) and Ba(OH)2.8H2O (3 equiv.) were 
added, and the mixture was heated at 100 ºC for 1h 30 min. Water and ethyl acetate  were added, the phases were 
separated, and then the aqueous phase was extracted with more ethyl acetate. The organic phases were collected, 
dried (MgSO4), filtered and then the solvent was evaporated at reduced pressure to give a brown solid, that was 
subjected to column chromatography.  
 
Boc-(Z)-∆Phe[β-(2,3,5-trimethylbenzo[b]thien-6-yl)]-OMe (Z)-2: The procedure described above was followed 
using compound 6-bromo-2,3,5-trimethylbenzo[b]thiophene (0.500 mmol, 128 mg) and Boc-(Z)-∆Phe(β-Br)-OMe 
(0.410 mmol, 147 mg), but adding water (200 µL) in the second step. Column chromatography using solvent 
gradient from neat petroleum ether to 30% diethyl ether/petroleum ether, gave product (Z)-2 (112 mg, 61%) as an 
oil. Crystallization from diethyl ether/n-hexane gave light-yellow solid, mp 154-156 ºC. 1H NMR (CDCl3): δ = 1.44 
(s, 9H, CH3 Boc), 2.31 (s, 3H, 5-CH3), 2.35 (s, 3H, ArCH3), 2.49 (s, 3H, ArCH3), 3.64 (s, 3H, OCH3), 5.80 (s, 1H, 
NH), 7.13-7.16 (m, 2H, ArH), 7.24-7.29 (m, 3H, ΑrΗ), 7.48 (broad s, 1H, ArH), 7.51 (s, 1H, ArH) ppm. 13C NMR 
(CDCl3): δ = 11.25 (CH3), 13.76 (CH3), 19.57 (CH3), 27.99 (C(CH3)3), 52.03 (OCH3), 81.22 (OC(CH3)3), 122.87 
(CH), 123.20 (CH), 126.50 (C), 126.73 (C), 127.56 (CH), 128.00 (CH), 128.41 (CH), 132.28 (C), 133.32 (C), 
135.21 (C), 135.91 (C), 139.17 (C), 141.22 (C), 152.48 (C=O), 166.30 (C=O) ppm.  MS: m / z (%) = 451 (22) [M+], 
351 (100) [M+ - Boc], 291 (34) [(M+-Boc)-CO2CH3]. HRMS: calcd. for C26H29NO4S [M+] 451.1817; found 
451.1801. 
 
Boc-(E)-∆Phe[β-(2,3,5-trimethylbenzo[b]thien-6-yl)]-OMe (E)-2: The procedure described above was followed 
using compound 6-bromo-2,3,5-trimethylbenzo[b]thiophene (0.460 mmol, 117 mg) and Boc-(E)-∆Phe(β-Br)-OMe 
(0.380 mmol, 136 mg), but adding water (200 µL) in the second step. Column chromatography using solvent 
gradient from neat petroleum ether to 30% diethyl ether/petroleum ether, gave product (E)-2 (51.0 mg, 30%) as an 
oil. Crystallization from petroleum ether gave white crystals, mp 156-157 ºC. 1H NMR (CDCl3): δ = 1.48 (s, 9H, 
CH3 Boc), 2.13 (s, 3H, ArCH3), 2.26 (s, 3H, ArCH3), 2.48 (s, 3H, ArCH3), 3.39 (s, 3H, OCH3), 6.26 (s, 1H, NH), 
7.24-7.34 (m, 6H, ArH), 7.51 (s, 1H, ΑrΗ) ppm. 13C NMR (CDCl3): δ = 11.35 (CH3), 13.82 (CH3), 20.25 (CH3), 
28.18 (C(CH3)3), 52.00 (OCH3), 81.21 (OC(CH3)3), 122.45 (CH), 122.54 (CH), 126.40 (C), 126.67 (C), 128.09 
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(CH), 128.63 (CH), 129.38 (CH), 132.98 (C), 134.29 (C), 135.06 (C), 137.52 (C), 140.98 (C), 152.99 (C=O), 166.24 
(C=O) ppm. C26H29NO4S (451.58): calcd. C 69.15, H 6.47, N 3.10, S 7.10; found C 68.90, H 6.54, N 3.14, S 7.03.  
 
Boc-(Z)-∆Phe[β-(2,3,7-trimethylbenzo[b]thien-6-yl)]-OMe (Z)-3: The procedure described above was followed 
using compound 6-bromo-2,3,7-trimethylbenzo[b]thiophene (0.500 mmol, 128 mg) and Boc-(Z)-∆Phe(β-Br)-OMe 
(0.500 mmol, 178 mg), but adding water (200 µL) in the second step. Column chromatography using solvent 
gradient from neat petroleum ether to 30% diethyl ether/petroleum ether, gave product (Z)-3 (122 mg, 52%) as an 
oil. Crystallization from petroleum ether gave white crystals, mp 149-150 ºC. 1H NMR (CDCl3): δ = 1.42 (s, 9H, 
CH3 Boc), 2.31 (s, 3H, ArCH3), 2.39 (s, 3H, 7-CH3), 2.53 (s, 3H, ArCH3), 3.62 (s, 3H, OCH3), 5.80 (s, 1H, NH), 
7.06 (d, J = 8.4 Hz, 1H, 5-H), 7.09-7.13 (m, 2H, ArH), 7.22-7.28 (m, 3H, ΑrΗ), 7.45 (d, J = 8.4 Hz, 1H, 4-H) ppm. 
13C NMR (CDCl3): δ = 11.42 (CH3), 13.84 (CH3), 17.59 (CH3), 28.08 (C(CH3)3), 52.07 (OCH3), 81.33 (OC(CH3)3), 
119.44 (CH), 126.53 (C), 126.93 (CH), 127.60 (CH), 127.90 (C), 128.06 (CH), 128.52 (CH), 130.04 (C), 133.02 
(C), 134.78 (C), 139.45 (C), 139.55 (C), 140.63 (C), 152.57 (C=O), 166.38 (C=O) ppm. C26H29NO5S (467.58): 
calcd. C 69.12, H 6.47, N 3.10, S 7.10; found C 69.15, H 6.63, N 3.11, S 6.91.  
 
Boc-(E)-∆Phe[β-(2,3,7-trimethylbenzo[b]thien-6-yl)]-OMe (E)-3: The procedure described above was followed 
using compound 6-bromo-2,3,7-trimethylbenzo[b]thiophene (0.310 mmol, 79.0 mg) and Boc-(E)-∆Phe(β-Br)-OMe 
(0.310 mmol, 111 mg), but adding water (125 µL) in the second step. Column chromatography using solvent 
gradient from neat petroleum ether to 30% diethyl ether/petroleum ether, gave product (E)-3 (41 mg, 43%) as an oil. 
Crystallization from petroleum ether gave light-yellow crystals, mp 172-173 ºC. 1H NMR (CDCl3): δ = 1.47 (s, 9H, 
CH3 Boc), 2.24 (s, 3H, ArCH3), 2.29 (s, 3H, ArCH3), 2.48 (s, 3H, ArCH3), 3.40 (s, 3H, OCH3), 6.24 (s, 1H, NH), 
7.15 (d, J = 8.1 Hz, 1H, ArH), 7.23-7.33 (m, 5H, ΑrΗ), 7.40 (d, J = 8.1 Hz, 1H, ArH) ppm. 13C NMR (CDCl3): δ = 
11.48 (CH3), 13.84 (CH3), 18.16 (CH3), 28.17 (C(CH3)3), 52.01 (OCH3), 81.21 (OC(CH3)3), 118.31 (CH), 126.43 
(CH), 126.59 (C), 127.81 (C), 128.04 (CH), 128.52 (C), 128.65 (CH), 129.28 (CH), 130.18 (C), 133.76 (C), 133.94 
(C), 138.17 (C), 139.17 (C), 140.52 (C), 152.97 (C=O), 166.27 (C=O) ppm. C26H29NO4S (451.58): calcd. C 69.15, 
H 6.47, N 3.10, S 7.10; found C 69.19, H 6.60, N 3.14, S 7.11.  
 
Boc-(Z)-∆Phe[β-(2,3-dimethyl-6-methoxybenzo[b]thien-7-yl)]-OMe (Z)-4: The procedure described above was 
followed using compound 7-bromo-2,3-dimethyl-6-methoxybenzo[b]thiophene (0.400 mmol, 108 mg) and Boc-(Z)-
∆Phe(β-Br)-OMe (0.400 mmol, 142 mg), but adding water (160 µL) in the second step. Column chromatography 
using solvent gradient from neat petroleum ether to 40% diethyl ether/petroleum ether, gave product (Z)-4 (100 mg, 
54%) as an yellow solid. Recrystallization from petroleum ether gave yellow crystals, mp 104-106 ºC. 1H NMR 
(CDCl3): δ = 1.41 (s, 9H, CH3 Boc), 2.26 (s, 3H, ArCH3), 2.37 (s, 3H, ArCH3), 3.59 (s, 3H, OCH3), 3.74 (s, 3H, 6-
OCH3), 5.86 (s, 1H, NH), 7.04 (d, J = 8.4 Hz, 1H, ArH), 7.20-7.24 (m, 5H, ΑrΗ), 7.53 (d, J = 8.4 Hz, 1H, ArH) 
ppm. 13C NMR (CDCl3): δ = 11.33 (CH3), 13.57 (CH3), 28.03 (C(CH3)3), 52.08 (OCH3), 56.48 (OCH3), 80.86 
(OC(CH3)3), 109.79 (CH), 119.50 (C), 121.93 (CH), 126.38 (C), 127.48 (CH), 127.77 (CH), 127.82 (C), 128.39 
(CH), 132.46 (C), 135.62 (C), 138.18 (C), 139.75 (C), 152.70 (C), 153.77 (C=O), 166.25 (C=O) ppm. C26H29NO5S 
(467.58): calcd. C 66.79, H 6.25, N 3.00, S 6.86; found C 66.93, H 6.62, N 2.96, S 6.63.  
 
Boc-(E)-∆Phe[β-(2,3-dimethyl-6-methoxybenzo[b]thien-7-yl)]-OMe (E)-4: The procedure described above was 
followed using compound 7-bromo-2,3-dimethyl-6-methoxybenzo[b]thiophene (0.340 mmol, 92.0 mg) and Boc-
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(E)-∆Phe(β-Br)-OMe (0.340 mmol, 119 mg), but adding water (134 µL) in the second step. Column 
chromatography using solvent gradient from neat petroleum ether to 40% diethyl ether/petroleum ether, gave 
product (E)-4 (63.0 mg, 40 %) as an yellow solid. Recrystallization from petroleum ether gave yellow crystals, mp 
135-136 ºC. 1H NMR (CDCl3): δ = 1.46 (s, 9H, CH3 Boc), 2.22 (s, 3H, ArCH3), 2.36 (s, 3H, ArCH3), 3.44 (s, 3H, 
OCH3), 3.78 (s, 3H, OCH3), 6.22 (s, 1H, NH), 6.99 (d, J = 8.7 Hz, 1H, ArH), 7.26-7.37 (m, 5H, ΑrΗ), 7.45 (d, J = 
8.7 Hz, 1H, ArH) ppm. 13C NMR (CDCl3): δ = 11.34 (CH3), 13.66 (CH3), 28.15 (C(CH3)3), 51.79 (OCH3), 56.64 
(OCH3), 80.92 (OC(CH3)3), 109.56 (CH), 121.12 (CH), 122.29 (C), 126.26 (C), 127.68 (C), 127.80 (C) 128.07 (C), 
128.48 (CH), 129.22 (CH), 132.04 (CH), 135.37 (C), 137.26 (C), 140.02 (C), 152.96 (C), 153.57 (C=O), 165.33 
(C=O) ppm. C26H29NO5S (467.58): calcd. C 66.79, H 6.25, N 3.00, S 6.86; found C 66.54, H 6.33, N 3.07, S 6.91. 
 
General Procedure for the synthesis of dehydroprolines: To a solution of the (Z)-
benzo[b]thienyldehydrophenylalanines (0.1 M) in DMF were added Pd(OAc)2 (50mol%) and Cu(OAc)2.H2O (3 
equiv.), and the mixture was heated at 100ºC, 130ºC or 160ºC, monitoring the reaction by TLC. Ethyl acetate (50 
mL) was then added and the organic layer washed with water and brine (2 x 25 mL), dried with MgSO4 ant the 
solvents were evaporated at reduce pressure to give an oil that was submitted to column chromatography. 
 
Methyl 3-(phenyl)-1H-4,6,7-trimethylbenzo[b]thien[7,6-b]pyrrole-2-carboxylate (6) and Methyl 3-(2,3,5-
trimethylbenzo[b]thien-6-yl)indole-2-carboxylate (5): The procedure described above was applied using 
compound (Z)-2 (0.177 mmol, 80.0 mg) and heating for 2h 30 min. at 160ºC. Column chromatography using solvent 
gradient from neat petroleum ether to 30% diethyl ether / petroleum ether, gave product 6 (12.0 mg, 20%) as a white 
solid, m.p. 215-217 ºC, as the less-polar product. UV(CH2Cl2): λmax (ε mol-1dm3cm-1) 333 (14750) 266 (30938) nm. 
1H NMR (CDCl3): δ = 2.10 (s, 3H, Ar-CH3), 2.32 (s, 3H, Ar-CH3), 2.54 (s, 3H, Ar-CH3), 3.74 (s, 3H, OCH3), 7.07 
(s, 1 H, ArH), 7.41 (s, 5 H, ArH), 9.07 (s largo, 1H, NH) ppm. 13C NMR (CDCl3): δ = 11.80 (CH3), 13.84 (CH3), 
20.62 (CH3), 51.64 (OCH3), 116.40 (CH), 118.53 (C), 121.87 (C), 123.47 (C), 126.82 (C), 127.14 (CH), 127.28 
(CH), 128.41 (C), 129.83 (C), 130.50 (CH), 132.09 (C), 135.88 (C), 139.94 (C), 162.23 (C=O). MS: m / z (%) = 349 
(85) [M+], 318 (26) [M+ - OCH3], 317 (100), 288 (28). HRMS: calc. for C21H19NO2S [M+] 349.1137; found 
349.1130. Product 5 eluted next with 40% diethyl ether / petroleum ether and was isolated as a white solid (37.0 mg, 
60%), m.p. 267-269 ºC. UV(CH2Cl2): λmax (ε mol-1 dm3cm-1) 296 (20875) 240 (48125)  1H NMR (CDCl3): δ = 2.23 
(s, 3 H, Ar-CH3), 2.35 (s, 3 H, Ar-CH3), 2.52 (s, 3 H, Ar-CH3), 3.75 (s, 3 H, OCH3), 7.12 (ap.t, 1H, ArH), 7.33-7.49 
(m, 3H, ArH), 7.54 (s, 1H, ArH), 7.63 (s, 1H, ArH), 9.04 (s largo, 1H, NH) ppm. 13C NMR (CDCl3): δ = 11.43 
(CH3), 13.84 (CH3), 20.40 (CH3), 51.84 (OCH3), 111.64 (CH), 120.72 (CH), 121.78 (CH), 121.93 (CH), 123.43 (C), 
123.71 (CH), 123.78 (C), 125.78 (CH), 126.69 (C), 128.54 (C), 129.33 (C), 133.38 (C), 133.84 (C), 135.07 (C), 
135.70 (C), 140.80 (C), 162.46 (C=O). MS: m/z (%) = 349 (100) [M+], 318 (15) [M+ - OCH3], 317 (41). HRMS: 
calc. for C21H19NO2S [M+] 349.1137; found 349.1126. 
 
Methyl N-(tert-butoxycarbonyl)-3-(2,3,7-trimethylbenzo[b]thien-6-yl)indole-2-carboxylate (7): The procedure 
described above was applied using compound (Z)-3 (0.310 mmol, 140 mg) and heating for 2h at 100ºC. Column 
chromatography using solvent gradient from neat petroleum ether to 10% diethyl ether / petroleum ether, gave 
compound (70.0 mg, 50%) as an oil. 1H NMR (CDCl3): δ = 1.70 (s, 9 H, CH3 Boc), 2.37 (s, 3 H, Ar-CH3), 2.38 (s, 3 
H, Ar-CH3), 2.56 (s, 3 H, Ar-CH3), 3.72 (s, 3 H, OCH3), 7.25-7.27 (m, 2 H, ArH), 7.32 (d, J = 8.1 Hz, 1 H, ArH), 
7.42-7.49 (m, 1 H, ArH), 7.53 (d, J = 8.1 Hz, 1 H, ArH), 8.23 (d, J = 8.4 Hz, 1 H, ArH) ppm. 13C NMR (CDCl3): δ = 
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11.47 (CH3), 13.82 (CH3), 18.38 (CH3), 27.91 (C(CH3)3), 52.19 (OCH3), 84.67 (OC(CH3)3), 115.10 (CH), 118.40 
(CH), 121.31 (CH), 123.33 (CH), 125.72 (C), 125.84 (C), 126.53 (CH), 127.03 (CH), 127.54 (C), 127.89 (C), 
129.25 (C), 130.78 (C), 134.00 (C), 135.93 (C), 138.91 (C), 140.72 (C), 149.30 (C=O), 163.03 (C=O). MS: m/z (%) 
= 449 (22) [M+], 349 (100) [M+ - Boc], 317 (43). HRMS: calc. for C26H27NO4S [M+] 449.1650; found 449.1661. 
 
Methyl 3-(2,3,7-trimethylbenzo[b]thien-6-yl)indole-2-carboxylate (8): The procedure described above was 
applied using compound (Z)-3 (0.137 mmol, 62.0 mg) and heating for 1h at 130ºC. Column chromatography using 
solvent gradient from neat petroleum ether to 20% diethyl ether / petroleum ether, gave compound 8 (41.0 mg, 85%) 
as a yellow solid, m.p. 230 -232 ºC. 1H NMR (CDCl3): δ = 2.34 (s, 3 H, Ar-CH3), 2.38 (s, 3 H, Ar-CH3), 2.56 (s, 3 
H, Ar-CH3), 3.77 (s, 3 H, OCH3), 7.14 (broad t, J = 6.9 Hz, 1H, ArH), 7.33-7.41 (m, 3 H, ArH), 7.48 (d, J = 9.0 Hz, 
1H, ArH), 7.54 (d, J = 8.1 Hz, 1 H, ArH), 9.21 (s largo, 1 H, NH) ppm. 13C NMR (CDCl3): δ = 11.52 (CH3), 13.84 
(CH3), 18.33 (CH3), 51.84 (OCH3), 111.70 (CH), 118.09 (CH), 120.70 (CH), 122.04 (CH), 123.50 (C), 125.73 (CH), 
127.55 (CH), 127.90 (C), 128.62 (C), 130.54 (C), 133.49 (C), 135.70 (C), 138.75 (C), 140.20 (C), 162.56 (C=O). 
MS: m / z (%) = 349 (100) [M+], 318 (17) [M+ - OCH3], 317 (46),  288 (22). HRMS: calc. for C21H19NO2S [M+] 
349.1137; found 349.1142. 
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